SynthesisJournal of the National Cancer Institute2020

Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis.

Francesco Schettini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.